Skip to main content

Table 2 Changes of liver function indexes and liver volume in 4 patients treated with TSH before and after the first surgery (M(IQR))

From: Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience

Variables

Before the first surgery

After the first surgery

Tbil (μmol/L)

9.29 (6.07–24.34)

11.93 (6.55–21.24)

Alb (g/L)

36.70 (34.93–46.80)

36.78 (30.49–42.50)

AST (U/L)

39.95 (17.90–67.55)

18.82 (18.05–36.96)

ALT (U/L)

60.50 (12.00–141.00)

17.32 (15.54–38.52)

GGT (U/L)

123.00 (28.50–392.70)

63.19 (28.20–92.50)

TLV (cm3)

1951.42 (1499.55–2051.45)

1648.57 (1256.03–2069.90)

LV (cm3)

667.53 (423.63–1034.05)

518.15 (202.63–1008.49)

FLRV (cm3)

492.05 (328.28–677.38)

779.75 (703.50–952.16)

FLRV/TLV (%)

29.88 (18.96–33.13)

52.01 (42.33–57.00)

  1. TSH two-stage hepatectomy, TBil total bilirubin, Alb albumin, AST aspartate transaminase, ALT alanine aminotransferase, GGT gamma-glutamyl transpeptidase, TLV total liver volume, LV lesions volume, FLRV future liver remnant volume
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us